Clinical Trial

Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi Arabia

Name: Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi Arabia — clinical trial record (NCT07603284)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BENEFIT-KSA

Active, Not Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This study aims to understand how using real-time continuous glucose monitoring (RT-CGM) can help people with Type-2 diabetes on insulin in Saudi Arabia.

Trial Details

NCT Number	NCT07603284
Lead Sponsor	DexCom, Inc.
Conditions	Type 2 Diabetes on Insulin
Enrollment	200 participants
Start Date	2025-11-24
Primary Completion	2026-11-02 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-22